We are live on ! Find out more
QI

QS Investors Portfolio holdings

AUM $8.47B
1-Year Est. Return 30.71%
This Fund
S&P 500
This Quarter Est. Return
+6.48%
1 Year Est. Return
+30.71%
3 Year Est. Return
+50.42%
5 Year Est. Return
+87.44%
10 Year Est. Return
AUM
$8.47B
AUM Growth
-$114M
Cap. Flow
-$591M
Cap. Flow %
-6.97%
Top 10 Hldgs %
45.26%
Holding
1,278
New
100
Increased
258
Reduced
472
Closed
184
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TPC
901
Tutor Perini Cor
TPC
$4.14B
$337K ﹤0.01%
24,300
INFI
902
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$336K ﹤0.01%
112,100
+400
+0.4% +$1.27K
MUR icon
903
Murphy Oil
MUR
$5.28B
$335K ﹤0.01%
14,366
AD
904
Array Digital Infrastructure
AD
$3.03B
$335K ﹤0.01%
9,220
LCII icon
905
LCI Industries
LCII
$2.63B
$334K ﹤0.01%
2,540
-35
-1% -$4.91K
AMTB icon
906
Amerant Bancorp
AMTB
$1.03B
$332K ﹤0.01%
15,517
XHR
907
Xenia Hotels & Resorts
XHR
$1.94B
$332K ﹤0.01%
17,679
XNCR icon
908
Xencor
XNCR
$1.3B
$332K ﹤0.01%
9,601
CMRX
909
DELISTED
Chimerix, Inc.
CMRX
$332K ﹤0.01%
41,401
-1,000
-2% -$8.31K
MRTX
910
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$331K ﹤0.01%
2,048
TWLO icon
911
Twilio
TWLO
$31.4B
$330K ﹤0.01%
837
INVA icon
912
Innoviva
INVA
$1.6B
$329K ﹤0.01%
24,500
BBBY
913
Bed Bath & Beyond
BBBY
$479M
$328K ﹤0.01%
3,911
-49
-1% -$3.56K
LUV icon
914
Southwest Airlines
LUV
$23.5B
$327K ﹤0.01%
6,142
-41
-0.7% -$2.46K
CDMO
915
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$325K ﹤0.01%
12,641
PTC icon
916
PTC
PTC
$14.4B
$324K ﹤0.01%
+2,290
New +$313K
CTMX icon
917
CytomX Therapeutics
CTMX
$788M
$322K ﹤0.01%
+50,800
New +$396K
AME icon
918
Ametek
AME
$54.3B
$321K ﹤0.01%
2,399
-44
-2% -$5.89K
AMPH icon
919
Amphastar Pharmaceuticals
AMPH
$871M
$321K ﹤0.01%
15,900
GEN icon
920
Gen Digital
GEN
$16.1B
$320K ﹤0.01%
11,726
-275
-2% -$6.85K
NOK icon
921
Nokia
NOK
$56.5B
$320K ﹤0.01%
+60,000
New +$289K
PEBO icon
922
Peoples Bancorp
PEBO
$1.42B
$320K ﹤0.01%
10,800
-8,080
-43% -$263K
KEYS icon
923
Keysight
KEYS
$54B
$319K ﹤0.01%
2,060
-41
-2% -$5.95K
RGNX icon
924
Regenxbio
RGNX
$511M
$319K ﹤0.01%
8,200
ZBRA icon
925
Zebra Technologies
ZBRA
$12.7B
$319K ﹤0.01%
601

Similar funds

QS Investors's Q2 2021 Portfolio in Review

As of Q2 2021, QS Investors held 1,278 positions worth $8.47B, down 1.3% from $8.58B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

QS Investors withdrew a net $591M in Q2 2021, closing 184 positions and reducing 472 holdings. Its most notable exit was Primo Water Corporation, an estimated $128M position sold in full.

By sector, the portfolio is most concentrated in Technology at 8.3% of assets, up from 8% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, QS Investors opened a new position in Vanguard Dividend Appreciation ETF worth $14.3M.

  • QS Investors's largest Q2 2021 buy was Vanguard Dividend Appreciation ETF: 92,373 shares worth $14.3M.
  • QS Investors added most to iShares Russell 1000 ETF in Q2 2021, an estimated $148M increase.
  • QS Investors's biggest Q2 2021 reduction was Vanguard Total Bond Market, cutting an estimated $150M.
  • QS Investors fully exited Primo Water Corporation in Q2 2021, selling an estimated $128M.
  • QS Investors's ten largest holdings make up 45% of its $8.47B portfolio in Q2 2021.
  • QS Investors opened 100 new positions and closed 184 in Q2 2021.
  • QS Investors's portfolio value fell 1.3% quarter-over-quarter to $8.47B.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.